Osteoporosis with increased osteoclastogenesis in hematopoietic cell-specific STAT3-deficient mice

被引:50
作者
Zhang, ZY
Welte, T
Troiano, N
Maher, SE
Fu, XY
Bothwell, ALM
机构
[1] Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA
[2] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06520 USA
[3] Yale Univ, Sch Med, Dept Orthopaed, New Haven, CT 06520 USA
[4] Yale Univ, Sch Med, Yale Core Ctr Musculoskeletal Disorders, New Haven, CT 06520 USA
关键词
osteoporosis; osteoclasts; STAT3; c-fos;
D O I
10.1016/j.bbrc.2005.01.019
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hematopoietic cell-specific disruption of the STAT3 gene induces hyperproliferation of cells of the myeloid lineage. Osteoclasts (OC), the bone-resorbing cells, are generated from the same precursors as monocyte/macrophages. STAT3 mutant mice exhibit decreased bone density, bone volume, and increased numbers of TRAP-positive OC. In vitro generation of OC showed significantly greater numbers of OC in mutant mice. The increased numbers of Mac1(+) cells and c-kit(+) cells were detected by FACS analysis, suggesting an increased number of OC precursors. Treatment of splenocytes with CSF-1 and RANKL significantly increased the Mac-1(+)RANK(+) cells, with much higher levels observed in cells from mutant mice compared with littermate controls. Besides enhanced number of Mac1(+) OC precursors, we also identified an OC-generating Mac1(-) c-kit(+) population in mutant mice which was absent in littermate controls. The Mac1(-) c-kit(-) cells did not generate OC. Finally, we determined that protein expression and mRNA level of c-fos, a transcription factor which is essential for OC differentiation, were enhanced in OC precursors of mutant mice, which may contribute to the osteopenic phenotype. (C) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:800 / 807
页数:8
相关论文
共 38 条
[1]   Mode of action of interleukin-6 on mature osteoclasts.: Novel interactions with extracellular Ca2+ sensing in the regulation of osteoclastic bone resorption [J].
Adebanjo, OA ;
Moonga, BS ;
Yamate, T ;
Sun, L ;
Minkin, C ;
Abe, E ;
Zaidi, M .
JOURNAL OF CELL BIOLOGY, 1998, 142 (05) :1347-1356
[2]   Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-Fms and receptor activator of nuclear factor κB (RANK) receptors [J].
Arai, F ;
Miyamoto, T ;
Ohneda, O ;
Inada, T ;
Sudo, T ;
Brasel, K ;
Miyata, T ;
Anderson, DM ;
Suda, T .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (12) :1741-1754
[3]  
Baron R.A., 1983, BONE HISTOMORPHOMETR, P13
[4]   Activation of the Janus kinase/STAT (signal transducer and activator of transcription) signal transduction pathway by interleukin-6-type cytokines promotes osteoblast differentiation [J].
Bellido, T ;
Borba, VZC ;
Roberson, P ;
Manolagas, SC .
ENDOCRINOLOGY, 1997, 138 (09) :3666-3676
[5]   STATs and gene regulation [J].
Darnell, JE .
SCIENCE, 1997, 277 (5332) :1630-1635
[6]   RANK is essential for osteoclast and lymph node development [J].
Dougall, WC ;
Glaccum, M ;
Charrier, K ;
Rohrbach, K ;
Brasel, K ;
De Smedt, T ;
Daro, E ;
Smith, J ;
Tometsko, ME ;
Maliszewski, CR ;
Armstrong, A ;
Shen, V ;
Bain, S ;
Cosman, D ;
Anderson, D ;
Morrissey, PJ ;
Peschon, JJ ;
Schuh, J .
GENES & DEVELOPMENT, 1999, 13 (18) :2412-2424
[7]   Requirement for NF-κB in osteoclast and B-cell development [J].
Franzoso, G ;
Carlson, L ;
Xing, LP ;
Poljak, L ;
Shores, EW ;
Brown, KD ;
Leonardi, A ;
Tran, T ;
Boyce, BF ;
Siebenlist, U .
GENES & DEVELOPMENT, 1997, 11 (24) :3482-3496
[8]  
Gattei V, 1996, CELL GROWTH DIFFER, V7, P753
[9]  
GRIGORIADIS AE, 1994, SCIENCE, V266, P433
[10]  
Hayashi S, 1997, J CELL PHYSIOL, V170, P241, DOI 10.1002/(SICI)1097-4652(199703)170:3<241::AID-JCP4>3.0.CO